Biobridge K.K. was founded in December 1983. Its main activities include importing pharmaceutical APIs, intermediates, and specialty chemicals, as well as acquiring orders from Japanese companies for the contract manufacturing of recombinant cell culture and microbial compounds, radio-labeled compounds, metabolism studies, and early phase clinical trials. It also serves as the registration agent and in-country caretaker for foreign pharmaceutical suppliers to Japanese regulatory agencies regarding foreign supplier accreditation, Drug Master Files, and support of GMP Conformity Inspections. The company intends to further expand its contribution to the Japanese and international pharmaceutical industries by assisting in the development of new chemical entities and by introducing new generic drugs to Japan.
BioBridge K.K. will continue to play a key role as a sales and marketing BRIDGE between European companies and the Japanese pharmaceutical industry.